These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 2990779

  • 1. Disorders of the hypothalamic-pituitary-adrenal axis.
    Wand GS, Ney RL.
    Clin Endocrinol Metab; 1985 Feb; 14(1):33-53. PubMed ID: 2990779
    [No Abstract] [Full Text] [Related]

  • 2. [Corticotropin releasing factor (CRF)-stimulating test in patients with disorders of the hypothalamo-pituitary-adrenal axis].
    Hashimoto K, Murakami K, Hattore T, Ota Z.
    Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1317-24. PubMed ID: 6097622
    [No Abstract] [Full Text] [Related]

  • 3. Serotonin, Cushing's disease, and depression.
    Sonino N, Fava GA.
    Psychother Psychosom; 1996 Sep; 65(2):63-5. PubMed ID: 8711083
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T, Yoshida A, Mikami K, Tamura Y, Yoshida S.
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract] [Full Text] [Related]

  • 5. The hypothalamic-pituitary-adrenal axis in critical illness.
    Johnson KL, Renn C.
    AACN Clin Issues; 2006 Feb; 17(1):39-49. PubMed ID: 16462408
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ito K.
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [Abstract] [Full Text] [Related]

  • 7. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY, Lowy MT, Koenig JI.
    Adv Biochem Psychopharmacol; 1987 Oct; 43():165-82. PubMed ID: 3035885
    [No Abstract] [Full Text] [Related]

  • 8. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.
    Stetler C, Miller GE.
    Psychosom Med; 2011 Oct; 73(2):114-26. PubMed ID: 21257974
    [Abstract] [Full Text] [Related]

  • 9. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL.
    Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597
    [Abstract] [Full Text] [Related]

  • 10. New targets for the clinical assessment of salivan cortisol secretion.
    Rosmond R, Björntorp P.
    J Endocrinol Invest; 2001 Sep; 24(8):639-41. PubMed ID: 11686548
    [No Abstract] [Full Text] [Related]

  • 11. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    Rayyis SS, Bethune JE.
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1231-7. PubMed ID: 4309156
    [No Abstract] [Full Text] [Related]

  • 12. [The function of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing syndrome].
    Luchitskiĭ EV, Valueva GV, Markov VV, Slavnov VN, Rybakov SI.
    Probl Endokrinol (Mosk); 1989 Sep; 35(6):38-42. PubMed ID: 2560186
    [Abstract] [Full Text] [Related]

  • 13. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K.
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed.
    Dickstein G.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):15-6. PubMed ID: 11167920
    [No Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing factor, a new aid in the diagnosis of pituitary-adrenal disorders?
    Hermus AR, Pieters GF, Smals AG, Kloppenborg PW.
    Neth J Med; 1985 Jan; 28(1):2-5. PubMed ID: 2983245
    [No Abstract] [Full Text] [Related]

  • 16. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
    Fiad TM, Kirby JM, Cunningham SK, McKenna TJ.
    Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
    [Abstract] [Full Text] [Related]

  • 17. Hypercortisolemia and depression.
    Gillespie CF, Nemeroff CB.
    Psychosom Med; 2005 May; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [Abstract] [Full Text] [Related]

  • 18. [Pituitary syndromes of diencephalic origin. Clinical application of pituitary stimulation tests].
    Ruedi B, Felber JP, Aubert M.
    Schweiz Med Wochenschr; 1968 Feb 03; 98(5):144-8. PubMed ID: 4298598
    [No Abstract] [Full Text] [Related]

  • 19. Normal cortisol response to corticotropin in patients with secondary adrenal failure.
    Cunningham SK, Moore A, McKenna TJ.
    Arch Intern Med; 1983 Dec 03; 143(12):2276-9. PubMed ID: 6316866
    [Abstract] [Full Text] [Related]

  • 20. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K, Montes-Montero A, Güemes I, González-Vives S, Díaz-Marsá M, Carrasco JL.
    Endocrinol Nutr; 2013 Dec 03; 60(7):396-403. PubMed ID: 23623464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.